Skip to main content
Fig. 2 | Clinical and Translational Medicine

Fig. 2

From: Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib

Fig. 2

Effect of dovitinib treatment on plasma miR levels of patients with metastatic breast cancer. MiRs were measured in plasma samples of patients collected before and after dovitinib treatment. The change in expression levels of six miRs relative to U6 in 8 patients at different treatment times (in weeks; w) is shown. The dashed lines indicate twofold up- or down-regulation of miR expression levels after treatment. The numbers on the x-axis indicate the patients. The color code of patients indicates changes in tumor sizes during treatment (red = increase, green = decrease, grey = no change)

Back to article page